Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

Independent healthcare communications consultancy POP Health has appointed Stephanie O’Hagan as Senior Director. O’Hagan has ...

The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...

Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...